Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

USA Today USA Today —

Novo Nordisk claims Eli Lilly aired misleading ads comparing the pharma companies' respective weight-loss drugs, Wegovy and Zepbound.

Read full article at USA Today →